跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
KETOROLAC TROMETHAMINE INJECTION, USP
Authorized
STANDARD
KETOROLAC TROMETHAMINE INJECTION, USP
Juno Pharmaceuticals Corp.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
bf163b5d75757dc0
Company
Juno Pharmaceuticals Corp.
Type
Standard
Approval Details
Approval Id
bf163b5d75757dc0
Drug Approval Canada Name
KETOROLAC TROMETHAMINE INJECTION, USP
Product Name
KETOROLAC TROMETHAMINE INJECTION, USP
Status
Marketed
Status Date
2021-07-27
Original Market Date
2016-04-26
Din
02443376
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intramuscular
Schedule
Prescription
Ahfs
28:08.04.92
Atc Original
M01AB15 KETOROLAC
Atc Name
m 01 ab 15
Aig Number
0121995002
Company Name
Juno Pharmaceuticals Corp.
Company Address
402, 2233 Argentia Road, Mississauga, Ontario, Canada, L5N 2X7
Active Ingredients
KETOROLAC TROMETHAMINE
30 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
bf163b5d75757dc0
Type
Standard
Back to Health Canada Approvals
KETOROLAC TROMETHAMINE INJECTION, USP - Health Canada Drug Approval Details